PMV Pharmaceuticals PMVP Growth Metrics (2019-2026)

NASDAQ PMVP
$1.36 -0.03 (-2.16%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

PMV Pharmaceuticals Quarterly Growth Metrics

Periods 27 quarters
Latest Jun 2026

PMV Pharmaceuticals reported revenue growth of -53.37% and asset growth of -46.31% for the quarter ended Jun 2026. These growth metrics cover 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-8.08%-9.29%-11.11%-15.55%-17.20%-18.48%-19.38%-19.41%-8.41%-6.72%-6.73%-1.93%-14.38%-24.14%-27.98%-35.65%-40.11%-39.06%-43.40%-46.31%
Assets Growth (3y)
37.92%-11.33%-11.64%-12.57%-12.61%-13.40%-16.75%-18.49%-20.18%-22.27%-24.45%-27.55%-30.29%
Assets Growth (5y)
13.17%-18.60%-20.43%-22.90%-25.43%
Assets (QoQ)
-3.30%-3.66%-4.99%-4.59%-5.18%-5.15%-6.05%-4.62%7.77%-3.40%-6.06%0.28%-5.91%-14.41%-10.81%-10.41%-12.44%-12.91%-17.16%-15.01%
Capital Expenditures Growth (1y)Capex Growth (1y)
1,152.50%2,800.00%1,760.00%665.02%163.27%-35.63%-79.66%-92.51%-96.66%-80.92%32.16%-100.75%-97.73%-72.41%-99.33%650.00%-200.00%-73.21%
Capital Expenditures Growth (3y)Capex Growth (3y)
107.25%3.23%52.71%71.00%-26.08%-87.41%-67.64%-87.85%-85.44%-26.01%-75.84%
Capital Expenditures Growth (5y)Capex Growth (5y)
-39.90%-15.16%-23.43%
Capital Expenditures (QoQ)Capex (QoQ)
7.51%229.94%35.03%59.72%-63.00%-19.33%-57.33%-41.19%-83.52%361.36%195.57%-100.33%150.00%5,500.00%-92.86%175.00%-109.09%1,600.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-52.66%-52.28%-44.55%-54.02%-43.47%-37.21%23.47%-21.68%-47.86%-65.18%-66.66%-28.86%-6.24%8.41%7.74%-9.07%-25.55%-7.08%-23.78%-71.74%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
13.91%-48.14%-52.92%-38.89%-36.49%-34.87%-38.11%-23.74%-20.28%-28.61%-29.48%-35.07%-43.25%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-11.02%-37.24%-36.27%-28.46%-41.97%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-6.75%-2.36%-32.87%-24.77%14.65%8.46%31.99%-52.28%-23.68%-27.57%26.38%1.83%0.59%-16.25%25.60%-14.05%-17.65%4.53%3.02%-68.13%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-108.62%13,361.40%72.25%-44.78%4,358.73%207.22%227.87%-318.63%-213.98%-111.14%-47.29%103.63%150.89%399.23%9.74%372.92%-29.74%138.17%-27.48%-211.30%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
48.15%113.83%-64.24%-83.57%-256.75%29.80%30.45%198.89%0.81%39.92%39.57%-25.86%-7.39%-25.14%42.39%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
19.31%45.40%-16.03%8.40%218.08%16.53%-2.99%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
93.43%1,190.76%-613.63%60.65%293.16%-21.31%113.78%-228.84%47.41%92.31%1,111.05%-91.12%636.93%-54.76%270.79%-61.74%9.48%53.34%12.90%-158.72%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-67.70%-16.64%-39.48%-48.03%-35.18%-27.40%16.59%5.69%6.56%21.14%-7.81%87.61%-7.54%-37.87%-12.86%-1,045.31%-17.70%-3.17%-7.74%20.35%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-44.05%-22.64%-23.22%-28.42%-5.43%-7.84%44.29%-10.74%-11.47%-0.49%-10.19%-5.75%-3.90%-9.44%-4.16%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-26.58%-17.55%-21.56%-21.80%-10.76%-8.81%-9.54%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-34.16%2.98%-49.63%24.00%-22.52%8.56%2.04%14.06%-21.38%22.82%-33.92%90.13%-953.75%1.06%-9.63%-0.20%-8.29%13.27%-14.49%25.93%
EBITDA Margin Growth (1y)
0.68M0.44M0.10M0.85M1.30M1.62M0.72M0.22M0.11M0.06M0.03M0.00M-0.02M-0.05M-0.05M-0.06M-0.07M-0.05M-0.08M-0.10M
EBITDA Margin Growth (3y)
0.06M0.11M0.09M0.44M2.09M2.12M0.85M1.08M1.39M1.63M0.70M0.16M0.02M-0.04M-0.10M-0.17M
EBITDA Margin Growth (5y)
0.15M0.12M0.07M0.37M2.00M2.02M0.71M0.91M
EBITDA Margin (QoQ)
-0.32M-0.26M0.93M0.51M0.12M0.05M0.03M0.02M0.01M0.01M0.00M-0.01M-0.01M-0.03M0.00M-0.02M-0.02M0.00M-0.04M-0.05M
EBIT Growth (1y)
-73.51%-75.91%-59.49%-37.05%-28.34%-14.56%-15.37%-12.51%-1.31%10.68%15.17%-0.24%-11.51%-33.15%-18.35%-13.43%-2.90%23.55%11.80%17.47%
EBIT Growth (3y)
-44.36%-42.23%-41.05%-35.52%-31.15%-21.64%-16.00%-15.62%-13.18%-10.86%-5.02%-8.55%-5.14%3.12%3.97%2.10%
EBIT Growth (5y)
-27.72%-27.89%-23.02%-23.13%-20.95%-12.88%-10.25%-7.67%
EBIT Margin Growth (1y)
0.70M0.45M0.10M0.86M1.31M1.62M0.72M0.22M0.11M0.06M0.03M0.00M-0.02M-0.05M-0.05M-0.06M-0.07M-0.05M-0.08M-0.10M
EBIT Margin Growth (3y)
0.06M0.11M0.10M0.44M2.11M2.13M0.85M1.08M1.40M1.63M0.70M0.16M0.02M-0.04M-0.10M-0.16M
EBIT Margin Growth (5y)
0.15M0.12M0.08M0.38M2.02M2.03M0.72M0.92M
EBIT Margin (QoQ)
-0.33M-0.26M0.93M0.52M0.12M0.05M0.03M0.02M0.01M0.01M0.00M-0.01M-0.01M-0.03M0.00M-0.02M-0.02M0.00M-0.04M-0.05M
EBIT (QoQ)
-15.69%-22.36%-0.80%3.94%-8.33%-9.22%-1.50%6.32%2.46%3.70%3.60%-10.70%-8.52%-14.99%14.32%-6.10%1.56%14.56%1.16%0.73%
EBT Growth (1y)
-71.12%-75.63%-58.92%-34.47%-21.65%-5.37%-3.78%-0.69%8.76%18.55%20.17%0.26%-15.10%-45.97%-28.57%-21.97%-9.99%21.69%8.12%14.72%
EBT Growth (3y)
-43.53%-40.02%-38.16%-29.82%-23.84%-14.66%-9.60%-10.53%-8.51%-7.80%-2.13%-7.00%-4.92%2.35%1.94%-1.23%
EBT Growth (5y)
-25.43%-26.69%-22.04%-21.63%-19.18%-11.50%-9.23%-7.03%
EBT Margin Growth (1y)
0.72M0.45M0.10M0.85M1.31M1.62M0.72M0.22M0.11M0.06M0.03M0.00M-0.02M-0.05M-0.05M-0.06M-0.07M-0.05M-0.08M-0.10M
EBT Margin Growth (3y)
0.06M0.12M0.10M0.44M2.13M2.13M0.85M1.08M1.40M1.63M0.70M0.16M0.02M-0.04M-0.10M-0.16M
EBT Margin Growth (5y)
0.15M0.12M0.08M0.38M2.05M2.03M0.72M0.91M
EBT Margin (QoQ)
-0.33M-0.26M0.93M0.52M0.12M0.05M0.03M0.02M0.01M0.01M0.00M-0.01M-0.01M-0.03M-894.00-0.02M-0.02M0.00M-0.04M-0.05M
EBT (QoQ)
-16.45%-22.46%-0.39%6.07%-5.35%-6.07%1.12%8.87%4.54%5.31%3.09%-13.86%-10.16%-20.09%14.64%-8.01%0.66%14.50%-0.15%-0.25%
EPS (Basic) Growth (1y)
77.23%44.11%-56.50%-32.98%-20.57%-4.31%-3.07%-0.20%15.09%22.66%28.97%93.81%-9.88%-35.89%-13.07%-1,630.67%-6.60%23.02%-0.78%16.93%
EPS (Basic) Growth (3y)
41.80%43.25%44.02%47.40%38.45%23.32%-4.64%56.47%-4.00%-3.11%6.10%-2.40%0.18%6.82%6.81%3.81%
EPS (Basic) Growth (5y)
28.73%28.11%32.42%31.04%22.86%13.95%-5.48%-3.47%
EPS (Basic) (QoQ)
-16.02%-22.73%0.32%6.31%-5.19%-6.19%1.51%8.92%10.86%3.28%9.55%92.06%-1,482.07%-19.62%24.74%-21.51%2.55%13.61%1.48%-0.16%
EPS (Diluted) Growth (1y)
44.11%49.80%57.62%-20.57%-4.31%-3.07%-0.20%15.09%22.66%28.97%93.81%-9.88%-35.89%-13.07%-1,630.67%-6.60%23.02%-0.78%16.93%
EPS (Diluted) Growth (3y)
23.32%28.37%70.26%-4.00%-3.11%6.10%-2.40%0.18%6.82%6.81%3.81%
EPS (Diluted) Growth (5y)
13.95%15.98%17.68%
EPS (Diluted) (QoQ)
63.02%-22.73%0.32%6.31%-5.19%-6.19%1.51%8.92%10.86%3.28%9.55%92.06%-1,482.07%-19.62%24.74%-21.51%2.55%13.61%1.48%-0.16%
FCF Margin Growth (1y)
0.59M0.87M0.13M0.57M1.10M1.20M0.82M0.24M0.11M0.05M0.01M0.04M-0.01M-0.03M-0.04M-0.10M-0.07M-0.07M-0.11M-0.08M
FCF Margin Growth (3y)
0.07M0.14M0.39M1.81M2.12M0.96M0.85M1.20M1.22M0.79M0.18M0.03M-0.05M-0.13M-0.14M
FCF Margin Growth (5y)
0.09M0.11M0.33M1.72M2.02M0.82M0.67M
FCF Margin (QoQ)
-0.41M-0.03M0.41M0.60M0.12M0.07M0.02M0.02M0.00M0.01M-0.02M0.05M-0.06M-0.01M-0.02M-0.01M-0.03M-0.01M-0.06M0.02M
Free Cash Flow Growth (1y)FCF Growth (1y)
-73.54%-31.94%-55.33%-77.64%-40.15%-19.79%23.55%23.64%13.14%25.02%-8.52%87.88%-7.24%-36.04%-8.85%-1,047.43%-17.69%-2.91%-7.71%20.40%
Free Cash Flow Growth (3y)FCF Growth (3y)
-47.31%-23.61%-24.06%-28.31%-5.82%-8.82%45.22%-9.29%-6.91%3.34%-2.03%-3.11%-1.63%-8.36%-3.45%
Free Cash Flow Growth (5y)FCF Growth (5y)
-26.67%-17.41%-21.57%-21.67%-10.66%-8.61%-8.47%
Free Cash Flow (QoQ)FCF (QoQ)
-32.88%-6.06%-47.87%14.76%-4.84%9.35%5.63%14.86%-19.25%21.75%-36.59%90.49%-955.14%0.73%-9.29%-0.24%-8.22%13.19%-14.39%25.93%
Net Cash Flow Growth (1y)NCF Growth (1y)
-104.33%64.41%62.86%-54.72%199.83%302.37%161.11%-160.56%-226.58%-270.30%-71.19%101.16%101.73%39.21%4.77%-932.91%-2,882.86%118.83%-89.05%-269.62%
Net Cash Flow Growth (3y)NCF Growth (3y)
-39.44%63.69%-80.17%-27.13%-7.04%27.35%26.97%26.45%-27.96%29.75%36.88%-37.69%-42.01%-67.91%29.08%
Net Cash Flow Growth (5y)NCF Growth (5y)
-17.40%22.16%-18.85%-15.17%16.44%14.96%-7.54%
Net Cash Flow (QoQ)NCF (QoQ)
31.05%67.34%-1,258.29%49.41%144.49%-33.80%310.15%-315.71%78.39%10.94%169.39%-91.32%-67.67%-3,223.21%219.59%-168.97%-8.03%121.14%-30.48%-2,428.47%
Net Income Growth (1y)
-71.26%-75.62%-58.88%-34.46%-21.44%-5.37%-3.77%-0.73%8.72%18.55%20.17%93.04%-15.54%-45.98%-14.18%-1,648.56%-9.53%21.58%-3.45%14.73%
Net Income Growth (3y)
-43.45%-40.02%-38.15%-29.84%-23.82%-14.65%-9.59%54.50%-8.60%-7.80%1.84%-7.01%-4.93%2.31%1.94%-1.23%
Net Income Growth (5y)
-25.50%-26.69%-19.17%-21.64%-19.16%-11.53%-9.23%-7.03%
Net Income (QoQ)
-16.60%-22.30%-0.40%6.09%-5.31%-6.12%1.12%8.85%4.57%5.31%3.08%92.06%-1,485.00%-19.63%24.19%-21.64%0.71%14.35%-0.01%-0.27%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-71.28%-75.62%-58.88%-34.46%-21.44%-5.37%-3.77%-0.73%8.72%18.55%20.17%93.04%-15.54%-45.98%-14.18%-1,648.56%-9.53%21.58%-3.45%14.73%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-43.45%-40.02%-38.15%-29.83%-23.83%-14.65%-9.59%54.50%-8.60%-7.80%1.84%-7.01%-4.93%2.31%1.94%-1.23%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-25.50%-26.69%-19.17%-21.63%-19.16%-11.53%-9.23%-7.03%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-16.60%-22.30%-0.40%6.09%-5.31%-6.12%1.12%8.85%4.57%5.31%3.08%92.06%-1,485.00%-19.63%24.19%-21.64%0.71%14.35%-0.01%-0.27%
Net Margin Growth (1y)
0.72M0.45M0.10M0.85M1.31M1.62M0.72M0.22M0.11M0.06M0.03M0.06M-0.02M-0.05M-0.04M-0.12M-0.07M-0.05M-0.09M-0.10M
Net Margin Growth (3y)
0.06M0.12M0.10M0.44M2.14M2.13M0.85M1.13M1.40M1.63M0.71M0.16M0.02M-0.04M-0.10M-0.16M
Net Margin Growth (5y)
0.15M0.12M0.09M0.38M2.05M2.03M0.72M0.91M
Net Margin (QoQ)
-0.33M-0.26M0.93M0.52M0.12M0.05M0.03M0.02M0.01M0.01M0.00M0.05M-0.07M-0.03M0.01M-0.04M-0.02M0.00M-0.04M-0.05M
Operating Income Growth (1y)Op. Inc Growth (1y)
-73.51%-75.91%-59.49%-37.05%-28.34%-14.56%-15.37%-12.51%-1.31%10.68%15.17%-0.24%-11.51%-33.15%-18.35%-13.43%-2.90%23.55%11.80%17.47%
Operating Income Growth (3y)Op. Inc Growth (3y)
-44.36%-42.23%-41.05%-35.52%-31.15%-21.64%-16.00%-15.62%-13.18%-10.86%-5.02%-8.55%-5.14%3.12%3.97%2.10%
Operating Income Growth (5y)Op. Inc Growth (5y)
-27.72%-27.89%-23.02%-23.13%-20.95%-12.88%-10.25%-7.67%
Operating Income (QoQ)Op. Inc (QoQ)
-15.69%-22.36%-0.80%3.94%-8.33%-9.22%-1.50%6.32%2.46%3.70%3.60%-10.70%-8.52%-14.99%14.32%-6.10%1.56%14.56%1.16%0.73%
Operating Margin Growth (1y)
0.70M0.45M0.10M0.86M1.31M1.62M0.72M0.22M0.11M0.06M0.03M0.00M-0.02M-0.05M-0.05M-0.06M-0.07M-0.05M-0.08M-0.10M
Operating Margin Growth (3y)
0.06M0.11M0.10M0.44M2.11M2.13M0.85M1.08M1.40M1.63M0.70M0.16M0.02M-0.04M-0.10M-0.16M
Operating Margin Growth (5y)
0.15M0.12M0.08M0.38M2.02M2.03M0.72M0.92M
Operating Margin (QoQ)
-0.33M-0.26M0.93M0.52M0.12M0.05M0.03M0.02M0.01M0.01M0.00M-0.01M-0.01M-0.03M0.00M-0.02M-0.02M0.00M-0.04M-0.05M
Profit After Tax Growth (1y)PAT Growth (1y)
-71.28%-75.62%-58.88%-34.46%-21.44%-5.37%-3.77%-0.73%8.72%18.55%20.17%93.04%-15.55%-45.98%-14.18%-1,648.56%-9.53%21.58%-3.45%14.73%
Profit After Tax Growth (3y)PAT Growth (3y)
-43.45%-40.02%-38.15%-29.83%-23.82%-14.65%-9.59%54.50%-8.60%-7.80%1.84%-7.01%-4.93%2.31%1.94%-1.23%
Profit After Tax Growth (5y)PAT Growth (5y)
-25.50%-26.69%-19.17%-21.63%-19.16%-11.53%-9.23%-7.03%
Profit After Tax (QoQ)PAT (QoQ)
-16.60%-22.30%-0.40%6.09%-5.31%-6.12%1.12%8.85%4.57%5.31%3.08%92.06%-1,485.00%-19.63%24.19%-21.64%0.71%14.35%-0.01%-0.27%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
143.28%443.06%651.51%596.01%614.92%254.53%114.55%27.69%8.59%-2.64%-2.98%-5.44%-6.39%-96.17%-96.55%-97.27%-97.48%-42.05%-46.01%-46.34%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
145.65%166.31%165.64%150.09%103.31%93.69%-49.04%-58.44%-67.95%-70.53%-72.14%-73.76%-76.00%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-11.16%-14.95%-16.07%-21.86%-34.25%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
11.25%121.66%69.51%66.49%14.28%9.92%2.58%-0.91%-2.82%-1.44%2.22%-3.42%-3.80%-95.96%-8.07%-23.67%-11.15%-7.06%-14.35%-24.14%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-781.00-923.000.00M0.00M-929.00-823.00-743.00-413.00-47.00161.00928.00651.00-143.00-702.000.00M0.00M0.00M0.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M-830.00-806.000.00M0.00M0.00M0.00M0.00M0.00M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.01M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-196.00-285.00-289.00-245.00-225.00-170.00-183.00-165.00105.00196.0025.00602.00-172.00-598.00-533.000.00M-769.00-440.000.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-829.00-994.000.00M0.00M0.00M0.00M0.00M-775.00-416.00-131.0065.00-230.000.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-210.00-316.00-304.00-270.00-281.00-243.00-289.00-295.0051.00117.00-3.00-99.00-243.00-777.00-760.00-908.00-936.00-545.00-964.000.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
679.00-880.000.00M0.00M0.00M0.00M-954.00-880.00-498.00-86.00138.000.00M689.00-163.00-651.000.00M0.00M0.00M0.00M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M0.00M0.00M-990.000.00M0.00M0.00M0.00M0.00M-0.01M-0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M-0.01M-0.01M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-233.00-319.00-328.00-276.00-258.00-203.00-218.00-201.00124.00209.007.00681.00-208.00-643.00-482.000.00M-944.00-566.000.00M0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.70M0.45M0.10M0.86M1.31M1.62M0.72M0.22M0.11M0.06M0.03M0.00M-0.02M-0.05M-0.05M-0.06M-0.07M-0.05M-0.08M-0.10M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.06M0.11M0.10M0.44M2.11M2.13M0.85M1.08M1.40M1.63M0.70M0.16M0.02M-0.04M-0.10M-0.16M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
0.15M0.12M0.08M0.38M2.02M2.03M0.72M0.92M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.33M-0.26M0.93M0.52M0.12M0.05M0.03M0.02M0.01M0.01M0.00M-0.01M-0.01M-0.03M0.00M-0.02M-0.02M0.00M-0.04M-0.05M
Revenue Growth (1y)
155.00%120.83%78.91%434.51%1,001.96%1,595.28%915.28%346.36%165.48%76.18%26.97%3.89%-12.37%-27.76%-34.45%-39.66%-43.40%-46.13%-49.35%-53.37%
Revenue Growth (3y)
60.47%78.49%78.91%157.99%320.97%304.04%184.64%191.57%194.87%178.39%103.68%40.91%9.61%-11.82%-25.02%-33.64%
Revenue Growth (5y)
57.25%48.56%36.66%60.84%105.89%91.37%50.25%47.47%
Revenue (QoQ)
-9.73%3.92%116.04%163.76%86.09%59.88%29.38%15.96%10.68%6.10%-6.76%-5.12%-6.64%-12.54%-15.39%-12.66%-12.43%-16.76%-20.45%-19.59%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
168.06%202.57%247.21%118.96%36.30%72.72%34.68%25.22%35.78%-2.82%-10.98%-12.24%-33.09%-57.15%-42.22%-39.72%-37.81%7.40%-7.69%-7.49%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
117.17%133.74%114.76%101.92%70.55%71.89%60.86%34.00%7.38%-10.40%-11.52%-12.83%-17.33%-23.53%-21.99%-21.20%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
56.22%39.68%38.49%34.21%15.60%18.51%17.29%6.06%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
56.17%-1.61%23.20%15.66%-2.78%24.67%-3.93%7.54%5.42%-10.77%-12.00%6.02%-19.62%-42.85%18.65%10.61%-17.09%-1.30%1.98%10.85%

PMV Pharmaceuticals Growth Metrics API

Pull PMV Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PMVP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY